🔎 Trials Near Me

Home › Pagkabigo ng Bato › Pennsylvania

Pag-aaral pangklinika para sa Pagkabigo ng Bato sa Pennsylvania

7 pag-aaral para sa Pagkabigo ng Bato ang naghahanap ng mga kalahok sa mga site sa Pennsylvania.

Mga Lungsod sa Pennsylvania

Opisyal na teksto ng pag-aaral (English)

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

  • Northeast Clinical Research Center, LLC, Bethlehem
  • Clinical Renal Associates, LTD, Exton
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT05485961

A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)

  • Research Site, Bethlehem
Nagre-recruitPhase 1/2Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 55 · Lahat ng kasarian · Na-update Ago 14, 2026 · NCT06749457

Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System

  • Butler Memorial Hospital, Butler
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 10, 2026 · NCT04634916

Virtual Reality in End Stage Kidney Disease

  • University of Pennsylvania, Philadelphia
Nagre-recruit
Lahat ng edad · Lahat ng kasarian · Na-update Hul 10, 2026 · NCT06356168

PReSeRVE-HD: Observational Study of the Merit HeRO® Graft and Super HeRO® in Patients on Hemodialysis

  • University Pittsburgh Medical Center, Pittsburgh
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 1, 2026 · NCT06422871

Kidney Transplant Improvement Through New Exercise Training to Increase Capacity

  • Perelman Center for Advanced Medicine, Philadelphia
Nagre-recruit
Edad 60 pataas · Lahat ng kasarian · Na-update May 6, 2026 · NCT07446296

A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease

  • Guthrie Clinic, Sayre
Nagre-recruit
Edad 18 hanggang 90 · Lahat ng kasarian · Na-update Dis 22, 2025 · NCT04671771

Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.